Keyphrases
Age Cohorts
8%
Anogenital Warts
50%
Canadian Institutes of Health Research
8%
Cervical Intraepithelial Neoplasia Grade 2
41%
Direct Impact
8%
Embase
8%
Genital Human Papillomavirus
8%
Herd Effect
100%
High-income Countries
8%
High-risk Human Papillomavirus (HR-HPV)
25%
HPV16
16%
Human Papillomavirus 31
8%
Human Papillomavirus Infection and Cervical Intraepithelial Neoplasia
8%
Human Papillomavirus Vaccine
100%
Impact Effect
100%
MEDLINE
8%
Meta-analysis
100%
Multi-cohort
8%
Multiple-ages
8%
Papillomavirus Infections
25%
Population Impact
100%
Population Recruitment
8%
Pre-vaccination
16%
Primary Appraisal
8%
Qubec
8%
Random Effects Model
8%
Recherche
8%
Recruitment Methods
8%
Relative Risk
100%
Revaccination
25%
Search Strategy
8%
Source Method
8%
Source Population
8%
Systematic Meta-analysis
100%
Vaccination
41%
Vaccination Coverage
8%
Vaccination Program
100%
Medicine and Dentistry
Cervical Intraepithelial Neoplasia
71%
Genital Wart
85%
Herd
100%
Human Papillomavirus Type 16
14%
Human Papillomavirus Type 18
14%
Human Papillomavirus Type 31
14%
Human Papillomavirus Type 33
14%
Human Papillomavirus Type 45
14%
Meta-Analysis
100%
Papillomavirus Infection
57%
Population
14%
Prevalence
57%
Random Effects Model
14%
Systematic Review
100%
Vaccination Coverage
14%
Wart Virus
100%
Wart Virus Vaccine
14%
Nursing and Health Professions
Condyloma acuminatum
42%
Embase
7%
Gardasil
7%
Meta Analysis
100%
Papillomavirus Infection
28%
Population
7%
Prevalence
28%
Systematic Review
100%
Uterine Cervix Carcinoma in Situ
35%
Vaccination Coverage
7%
Vaccination Policy
100%
World Health Organization
7%
Immunology and Microbiology
Cervarix
6%
Embase
6%
Herd
100%
Human Papillomavirus Type 16
6%
Human Papillomavirus Type 18
6%
Human Papillomavirus Type 31
6%
Human Papillomavirus Type 33
6%
Human Papillomavirus Type 45
6%
Population
6%
Prevalence
26%
Vaccination Policy
100%
Wart Virus
100%